(Press-News.org) Scientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a single injection, a feat with profound implications for patients with neurological diseases.
In tests that also included patient derived cells, the cutting-edge technique not only fixed mutations causing alternating hemiplegia in childhood (AHC) — it also reduced symptoms and extended survival in mice that had AHC and were otherwise at risk of sudden death.
The research, led by the Rare Disease Translational Center (RDTC) at The Jackson Laboratory (JAX), the Broad Institute, and the nonprofit RARE Hope, was years in the making and follows the first successful gene-editing treatment for a rare liver disease. It offers a powerful glimpse into the potential of personalized gene-editing for neurological conditions.
The findings were published today in Cell.
“Five years ago, people would have thought that going into the brain of a living organism and correcting DNA was science fiction. Today, we know this is doable,” said Markus Terrey, a JAX neuroscientist who co-led the work. “Doing this directly in the brain of a living organism is scientifically fascinating. You can go into the brain, fix the mutation, and have the cells corrected for the rest of their life.”
A breakthrough in gene editing
AHC typically begins during infancy and causes sudden episodes of paralysis that can last minutes or even days. These episodes may be accompanied by dystonia (muscle stiffness), eye movement issues, and developmental delays. Seizures are a significant and life-threatening component of the disease, which currently has no cure. While existing treatments aid with symptom management, they have limited effectiveness.
The scientists targeted the two most common mutations that cause AHC, known as D801N and E815K, in a gene called ATP1A3. They relied on new mouse models developed by Terrey and Cathleen (Cat) Lutz, vice president of the RDTC. Previous efforts at replicating these mutations in mice resulted in defects like those observed in AHC in humans, with mice perishing prematurely and spontaneously.
The research also has important implications for other rare genetic diseases that have long been considered incurable and have been neglected because of their complexity and rarity, Lutz said. “The idea of correcting mutations of rare diseases before someone ever develops symptoms is compelling, but it requires the development of technologies to do just that,” Lutz said. “With partners and experts in the field, we develop and test these technologies for devastating diseases with very clear, early symptoms like AHC.”
RARE Hope (formerly Hope for Annabel), a nonprofit advancing AHC research and developing scalable cross-disease platforms, has been a longstanding and vital partner in the project. The organization helped integrate patient priorities into the research and connected scientists at JAX and the Broad Institute with an international network of AHC experts and families. RARE Hope ensured that experimental design, endpoint selection, and data interpretation all reflected patient perspectives—insights that were crucial in designing and validating tools to correct ATP1A3 mutations.
"While the incidence of this disease is very rare, the incidence of monogenic, rare conditions that could be addressed with gene editing is actually a really big number. The impact of this success resonates far beyond AHC,” said Nina Frost, founder and president of RARE Hope, a co-author of the study, and mother of a daughter with AHC. “Up until this point, we didn't know if this was a disease that could be rescued postnatally. To see data that showed not just molecular correction in cells, but a functional rescue in mouse behavior, was an incredibly exciting moment.”
The team tested two next-generation techniques to correct mutations in genetically modified AHC mice. Prime editing, a technique that edits DNA letters, proved to be far more applicable than another approach called gene therapy, a more widely used therapeutic approach where healthy copies of an otherwise faulty gene are added. Prime editing corrected up to 85% of the faulty gene mutations in brain cells, restoring normal protein function, improving motor skills, reducing seizure-like episodes, and extending lifespan in mice.
“We're not working with a patient at this point, but to have this kind of demonstration in a mouse with this level of correction is a pretty big deal,” Terrey said. “If we can do it for one gene variant—and we already have five in the paper—we can reasonably assume that we can do this for other variants as well. We can expand this work towards other rare diseases, because 80% of them are genetic. We know exactly where the problem is.”
The treatments were delivered through a single injection into the brain. They consisted of a harmless virus called AAV9 that is commonly used as a delivery vehicle in CRISPR-based gene editing, which scientists use to make precise changes to DNA. This was done shortly after birth, allowing gene editing tools to reach a large number of neurons early in life. Additionally, the team found minimal off-target effects in patient-derived cells, suggesting the approach could be both effective and safe.
Toward personalized genetic therapies
The success of the approach is a milestone that contributes to the momentum gene editing and gene therapy approaches are gaining, such as the recent breakthrough of the first gene editing treatment that healed an infant with a rare genetic liver disorder called CPS1 deficiency in May. Now, the ability to edit DNA directly in the brain offers promising new implications for neurological diseases, the scientists said.
“A lot of these delivery approaches for gene editing are viruses or nanoparticles that are relatively easily soaked up by the liver and peripheral organs, but getting across the blood brain barrier, which has this very complex set of endothelial cells that, for very good reasons, keep viruses away from the brain, is completely different,” Lutz said. “This level of editing efficiency in the brain is really quite remarkable.”
As the lead investigator of the NIH Somatic Cell Genome Editing Consortium, Lutz has been a longtime collaborator with David Liu, a Core Member of the Broad Institute and co-senior author of the study who developed prime editing in 2019. By leading efforts that go beyond preclinical models, the consortium is helping position genome editing as a viable therapeutic platform, with the latest research being just one example of the powerful outcomes made possible through that collaboration, she said.
“This study is an important milestone for prime editing and one of the most exciting examples of therapeutic gene editing to come from our team,” Liu said. “It opens the door to one day repairing the underlying genetic causes of many neurological disorders that have long been considered untreatable.”
The team is now working to test the period that provides the safest and most effective results after gene editing to reverse, rather than prevent, AHC in mice.
“We haven’t necessarily reversed the disease, but we’ve shown we can ameliorate symptoms when treatment was given very early on when the animals were born,” Lutz said. “The money shot, which we’re working on now, is testing whether we can treat the disease after symptoms appear—when the mice are already showing signs like dystonia and epilepsy. If we can show benefit then, that’s a whole new level. That would be a major step forward.”
END
Genome editing corrected rare brain mutations in mice. Could it help fight neurological diseases?
Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood
2025-07-21
ELSE PRESS RELEASES FROM THIS DATE:
Prime editing treats childhood brain disease in mice
2025-07-21
Prime editing treats childhood brain disease in mice
Scientists use a precise form of gene editing called prime editing to correct the most common genetic mutations that cause alternating hemiplegia of childhood, a rare and severe neurological disorder that begins in infancy.
July 21, 2025 (Cambridge, MA) — By the time they are a few months old, infants born with alternating hemiplegia of childhood (AHC) begin experiencing terrifying episodes of paralysis and seizures, and will soon show developmental delays and intellectual disability. There is no cure or effective treatment for this rare genetic disease, but new research suggests a potential path to one.
Researchers ...
Estimated out-of-pocket costs for patients with common cancers and private insurance
2025-07-21
About The Study: In this study of individuals with private insurance, patients faced high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with patients with more advanced cancer having the highest OOPCs. Further research is needed to determine the clinical and financial effects of increased OOPCs for patients with cancer.
Corresponding Author: To contact the corresponding author, Liam Rose, PhD, email liamrose@stanford.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.21575)
Editor’s ...
Finding human brain genes in duplicated DNA
2025-07-21
What makes the human brain distinctive? A new study published July 21 in Cell identifies two genes linked to human brain features and provides a road map to discover many more. The research could lead to insights into the functioning and evolution of the human brain, as well as the roots of language disorders and autism.
The newly characterized genes are found among the “dark matter” of the human genome: regions of DNA that contain a lot of duplicated or repeat sequences, making them difficult to study until recently. If assembling ...
SwRI experiments may explain mysterious distribution of hydrogen peroxide on Europa
2025-07-21
SAN ANTONIO — July 21, 2025 — Southwest Research Institute (SwRI) scientists conducted lab experiments to address a mystery about the origins of frozen hydrogen peroxide (H2O2) on Jupiter’s icy moon Europa. Their results, published in the July 2025 issue of Planetary Science Journal, may help explain puzzling observations made by the James Webb Space Telescope (JWST).
Scientists studying the telescope data noticed elevated levels of hydrogen peroxide on Europa in unexpected areas. Decades of lab studies suggested higher concentrations ...
New research reveals how autistic teens’ brains respond in some social settings, helping them ‘pass’ as non-autistic
2025-07-21
Some autistic teens often adopt behaviors to mask their diagnosis in social settings helping them be perceived — or “pass” — as non-autistic. For the first time, researchers are able to observe brain functions that differ in those who “pass as non-autistic,” which could lead to a better understanding of the cognitive toll of this kind of masking, and of how these individuals could be more effectively supported.
Using an electroencephalogram (EEG) to measure brainwaves, researchers from Drexel University’s A.J. Drexel Autism Institute found that teens who pass as non-autistic ...
GLP-1 drugs fail to provide key long-term health benefit
2025-07-21
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper.
The researchers emphasize that weight loss associated with GLP-1 drugs has many clear health benefits for people with obesity, type 2 diabetes and heart failure, including improving blood-sugar control, short-term cardiorenal benefits and improvements in survival outcomes. But doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help ...
FloodPlanet dataset enhances global inundation monitoring
2025-07-21
A new high-resolution flood dataset, FloodPlanet, is enhancing satellite-based flood monitoring through more accurate training of deep learning models. By manually labeling inundation data from commercial satellites and aligning them with public sensor imagery, researchers improved flood detection accuracy by up to 15.6%. This work addresses critical limitations in current flood mapping and opens the door for more reliable global inundation response systems.
Flooding affects more people globally than any other environmental hazard, yet accurate ...
Focus in flashes: How the brain handles overload
2025-07-21
Recent research shows that your brain doesn’t pay attention in one smooth stream—instead, it switches focus in quick bursts, about 8 times per second. This process, called “attentional sampling,” helps your brain deal with too much information by jumping back and forth between different things you're seeing. It’s kind of like your brain is taking rapid snapshots instead of watching a constant video. And when you need to focus on more than one thing, the rhythm splits to allow focusing on each one around 4 times ...
Breaking the crystalline barrier: Amorphous nanomaterials in advanced photocatalysis
2025-07-21
Photocatalysis, a technology that converts solar energy into chemical reactions, holds immense promise for addressing energy shortages and environmental pollution. However, traditional crystalline semiconductors face limitations in efficiency and stability. A groundbreaking review led by researchers from China Three Gorges University and Capital Normal University unveils how amorphous nanomaterials, which are lacking of long-range atomic order, could overcome these barriers and provide a new thought of advanced photocatalysis.
Published in Nano Research, the ...
SwRI’s Sidney Chocron named Ballistics Science Fellow
2025-07-21
SAN ANTONIO — July 21, 2025 —Southwest Research Institute’s (SwRI) Dr. Sidney Chocron has been named a Ballistic Science Fellow by the International Ballistics Society. The honor is awarded to members who have made numerous contributions to ballistics science.
Chocron specializes in the nonlinear response of materials under high strain rates. His work primarily focuses on unconventional tests and computer modeling of materials, such as his research studying the impact of foam and ice on the Space Shuttle thermal protection ...
LAST 30 PRESS RELEASES:
Solvent selection tool boosts thermoelectric devices
Collecting large-scale data from impoverished communities
Neuroanatomy of social dominance
Reference genomes for rice’s wild relatives may boost future crops
How AI can enhance early detection of emerging viruses: UNLV study
Surface structure engineering of PtCu clusters enhances the performance of propane dehydrogenation
Gemini North discovers long-predicted stellar companion of Betelgeuse
Hollow molecules offer sustainable hydrocarbon separation
High-performance near-Infrared computational spectrometer enabled by finely-tuned PbS quantum dots
Hyaluronidase nanogel-armed CAR-T cell for improving efficacy against solid tumors
Tailored hard/soft magnetic heterostructure anchored on 2D carbon nanosheet for efficient microwave absorption and anti-corrosion property
A novel strategy for modulating the crystalline-amorphous composites and electronic structure to enhance hydrogen evolution reaction
Metal-free catalysts break through in green H2O2 synthesis! Novel organic semiconductors enable high-efficiency interfacial reactions
Do these two cancer drugs have what it takes to beat Alzheimer’s?
Genome editing corrected rare brain mutations in mice. Could it help fight neurological diseases?
Prime editing treats childhood brain disease in mice
Estimated out-of-pocket costs for patients with common cancers and private insurance
Finding human brain genes in duplicated DNA
SwRI experiments may explain mysterious distribution of hydrogen peroxide on Europa
New research reveals how autistic teens’ brains respond in some social settings, helping them ‘pass’ as non-autistic
GLP-1 drugs fail to provide key long-term health benefit
FloodPlanet dataset enhances global inundation monitoring
Focus in flashes: How the brain handles overload
Breaking the crystalline barrier: Amorphous nanomaterials in advanced photocatalysis
SwRI’s Sidney Chocron named Ballistics Science Fellow
Turning waste alkaline water directly into clean hydrogen!
Astronomers witness newborn planet sculpting the dust around it
AI vision, reinvented: The power of synthetic data
Chemical shield stops stressed DNA from triggering disease
Genetic test predicts obesity in childhood
[Press-News.org] Genome editing corrected rare brain mutations in mice. Could it help fight neurological diseases?Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood